Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	16
Overall Study	STARTED	20 mg AZD4901 Once Daily	15
Overall Study	STARTED	20 mg AZD4901 Twice Daily	17
Overall Study	STARTED	40 mg AZD4901 Twice Daily	17
Overall Study	COMPLETED	Placebo	16
Overall Study	COMPLETED	20 mg AZD4901 Once Daily	15
Overall Study	COMPLETED	20 mg AZD4901 Twice Daily	14
Overall Study	COMPLETED	40 mg AZD4901 Twice Daily	15
Overall Study	NOT COMPLETED	Placebo	0
Overall Study	NOT COMPLETED	20 mg AZD4901 Once Daily	0
Overall Study	NOT COMPLETED	20 mg AZD4901 Twice Daily	3
Overall Study	NOT COMPLETED	40 mg AZD4901 Twice Daily	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01872078/flow